Publication | Closed Access

Duration of Benefit in Patients With Autoimmune Pulmonary Alveolar Proteinosis After Inhaled Granulocyte-Macrophage Colony-Stimulating Factor Therapy

Pulmonary CareAutoimmune DiseaseAllergyAdvanced Lung DiseaseImmunologyPulmonary Alveolar ProteinosisPulmonary FibrosisAutoimmunityImmunotherapyMedicineMatrikinesPulmonary Disease